Toggle Main Menu Toggle Search

Open Access padlockePrints

Defective removal of ribonucleotides from DNA promotes systemic autoimmunity

Lookup NU author(s): Dr Alice Lorenzi, Professor John IsaacsORCiD

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Abstract

Genome integrity is continuously challenged by the DNA damage that arises during normal cell metabolism. Biallelic mutations in the genes encoding the genome surveillance enzyme ribonuclease H2 (RNase H2) cause Aicardi-Goutieres syndrome (AGS), a pediatric disorder that shares features with the autoimmune disease systemic lupus erythematosus (SLE). Here we determined that heterozygous parents of AGS patients exhibit an intermediate autoimmune phenotype and demonstrated a genetic association between rare RNASEH2 sequence variants and SLE. Evaluation of patient cells revealed that SLE- and AGS-associated mutations impair RNase H2 function and result in accumulation of ribonucleotides in genomic DNA. The ensuing chronic low level of DNA damage triggered a DNA damage response characterized by constitutive p53 phosphorylation and senescence. Patient fibroblasts exhibited constitutive upregulation of IFN-stimulated genes and an enhanced type I IFN response to the immunostimulatory nucleic acid polyinosinic:polycytidylic acid and UV light irradiation, linking RNase H2 deficiency to potentiation of innate immune signaling. Moreover, UV-induced cyclobutane pyrimidine dimer formation was markedly enhanced in ribonucleotide-containing DNA, providing a mechanism for photosensitivity in RNase H2-associated SLE. Collectively, our findings implicate RNase H2 in the pathogenesis of SLE and suggest a role of DNA damage-associated pathways in the initiation of autoimmunity.


Publication metadata

Author(s): Gunther C, Kind B, Reijns MAM, Berndt N, Martinez-Bueno M, Wolf C, Tungler V, Chara O, Lee YA, Hubner N, Bicknell L, Blum S, Krug C, Schmidt F, Kretschmer S, Koss S, Astell KR, Ramantani G, Bauerfeind A, Morris DL, Graham DSC, Bubeck D, Leitch A, Ralston SH, Blackburn EA, Gahr M, Witte T, Vyse TJ, Melchers I, Mangold E, Nothen MM, Aringer M, Kuhn A, Luthke K, Unger L, Bley A, Lorenzi A, Isaacs JD, Alexopoulou D, Conrad K, Dahl A, Roers A, Alarcon-Riquelme ME, Jackson AP, Lee-Kirsch MA

Publication type: Article

Publication status: Published

Journal: Journal of Clinical Investigation

Year: 2015

Volume: 125

Issue: 1

Pages: 413-424

Print publication date: 02/01/2015

Online publication date: 15/12/2014

Acceptance date: 09/10/2014

ISSN (print): 0021-9738

ISSN (electronic): 1558-8238

Publisher: American Society for Clinical Investigation

URL: http://dx.doi.org/10.1172/JCI78001

DOI: 10.1172/JCI78001


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
Biotechnology and Biological Sciences Research Council
MRC Senior Clinical Fellowship
Wellcome Trust
European Science Foundation
Friede Springer Stiftung
Fundacion Raman Areces
Lister Institute Prize Fellowship
02558ISCIII through FEDER funds of the European Union
BMBF 01 GM 0310/0634German Federal Ministry of Education and Research
GU1212/1-2DFG
KFO 249/AR2133/6-1DFG
KFO 249/GU1212/1-1DFG
KFO 249/LE1074/4-1DFG
LE1074/4-2DFG

Share